Skip to main content
Clinical Trials/ACTRN12614001194651
ACTRN12614001194651
Completed
未知

In patients undergoing percutaneous liver biopsy, do prophylactic use of pethidine, compared to no treatment, reduce the anxiety and post procedural pain relief

Gastroenterology unit, Dunedin Hospital0 sites100 target enrollmentNovember 13, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Gastroenterology unit, Dunedin Hospital
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 13, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gastroenterology unit, Dunedin Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients undergo percutaneous liver biopsy at Dunedin hospital

Exclusion Criteria

  • 1\) Patients with previous allergic reaction to pethidine or metoclopramide; 2\) Patients with clotting disorders and abnormal prothrombin time with international normalized ratio (INR) of greater than 1\.5 or thrombocytopenia with platelet less than 50 x 109 per litre; 3\) abdominal ultrasound revealed a contraindication to PLB such as massive ascites, intrahepatic duct dilatation, or focal lesion; 4\) patients without a telephone for study follow up; and 5\) patients with a solitary lesion that required target biopsy under ultrasound guidance

Outcomes

Primary Outcomes

Not specified

Similar Trials